Alison Bauerlein

Alison Bauerlein is a declared insider at 4 companies (chief executive); the most frequent names are Sight Sciences, Inc., Inogen Inc and Gelesis Holdings, Inc. In total, 28 filings cover trades dated from 8 February 2016 to 2 October 2026.

Sales make up the whole of the open-market record (13 sales, €931k). Outside the open market, there are 7 share grants and 8 option exercises. So far in 2026, the count stands at no purchases and 4 sales.

The record was last updated on 5 October 2026 with an open-market sale (€199k) in Sight Sciences, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.